acetylsalicylic acid
Drug75-100mg,per day
Other names: Aspirin
NCT Number: NCT02261025
The aim of present study is to examine the effect of low-dose aspirin on the incidence of cardiovascular events and mortality in patients undergoing chronic hemodialysis.
Looking for future studies?
Notify Me18 year–85 year
All sexes
Interventional
Not applicable
This study prospectively evaluate the impacts of low dose aspirin on survival and cardio-cerebral vascular events in a large cohort of Chinese patients undergoing chronic hemodialysis. Between January 2008, consecutive patients with hemodialysis with aspirin were enrolled.We examine the association of aspirin with all-cause mortality in patients matched by propensity scores using the Kaplan-Meier method and Cox models in "intention-to-treat" analyses.The secondary endpoint was rate of cardio-cerebral events.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
All patients aged 18 to 85, undergoing chronic hemodialysis, who have none of the following exclusion criteria.
Exclusion criteria
History of gastric or duodenal ulcers Known allergy to aspirin or other NSAIDs
-
75-100mg,per day
Other names: Aspirin
Time frame: 5 years
Time frame: 5 years
Shanghai Jiao Tong University School of Medicine
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07704008
Anxiety Disorders, Female Urogenital Diseases
Ankara, Turkey (Türkiye)
View Trial DetailsNCT07334522
Agnosia, Anxiety
Karbala, Iraq
View Trial DetailsNCT06759376
Chronic Disease, Chronic Kidney Disease
Eskişehir, Turkiye, Turkey (Türkiye)
View Trial DetailsNCT07687498
Chronic Disease, Disease Attributes
Mersin, Yenişehir, Turkey (Türkiye)
View Trial Details